More than health risks play a role in compliance with coronavirus measures The risk of COVID-19 is not the only factor that determines compliance with the coronavirus measures; other risks also play a role.
No evidence of more serious illness from COVID-19 among Q fever patients There are no indications that people who previously had Q fever had a more serious course of illness from the coronavirus SARS-CoV-2. This is evident from RIVM research.
Launch of Integrated Health Monitor COVID-19: large-scale study on public health impact of COVID-19 RIVM, the collective Municipal Public Health Services (GGDs) in collaboration with GGD GHOR, the NIVEL Netherlands Institute for Health Services Research and ARQ National Psychotrauma Centre have developed a new monitor: the Integrated Health Monitor
Insight into hospital admissions for acute respiratory infections In order to achieve an accurate overview of how often respiratory infections occur in the Netherlands, it is important to know how many patients are admitted to hospital with a respiratory infection.
Hospital admissions appear to have peaked, 44% fewer positive COVID-19 tests 541 new COVID-19 hospital admissions were reported last week, 23 fewer than in the week before, when 564 people with COVID-19 were admitted to hospital.
Long COVID also possible after a mild case: interim research results More than 95% of the 1,741 participants in RIVM’s LongCOVID study, who reported long-term symptoms after COVID-19, had mild symptoms during the acute phase of the infection.
Number of positive COVID-19 tests doubled in one week In the past week from 30 June to 6 July 2021, the number of reported positive COVID-19 tests doubled (+103%) compared to the previous week. This increase was observed in all security regions.
Delta variant on the rise The delta variant of the coronavirus SARS-CoV-2 is occurring more and more often in the Netherlands.
Effects of COVID-19 vaccination becoming increasingly visible In the past calendar week, there were 43% fewer hospital admissions of patients with COVID-19 compared to the week before.
Quality assessment of SARS-CoV-2 antigen test diagnostics: good performance at public test sites in the Netherlands In their role as WHO reference laboratories, RIVM and Erasmus UMC conducted a study on the quality of SARS-CoV-2 antigen diagnostics in the Netherlands.